Telehealth startup Cerebral under investigation over prescriptions for controlled substances
by Nicole Wetsman from The Verge - All Posts on (#5Z183)
Image: Cerebral Mental health startup Cerebral is under investigation by the US Department of Justice over its prescribing of controlled substances like Adderall and Xanax. The company received a grand jury subpoena asking for documents from the US Attorney for the Eastern District of New York on May 4, Insider first reported.
The company said the same day that it was pausing its prescriptions for controlled substances for new patients.
Cerebral offers therapy and counseling for conditions like anxiety, insomnia, and ADHD. Unlike some other online mental health services, it also offers prescriptions for controlled substances used to treat some of those conditions.
The company's advertising and prescribing practices have been under scrutiny by medical...